U.S. Physical Therapy, Inc. (NYSE:USPH) Stock Position Cut by Boston Trust Walden Corp

Boston Trust Walden Corp cut its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 1.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 510,819 shares of the company's stock after selling 7,856 shares during the period. Boston Trust Walden Corp owned about 3.36% of U.S. Physical Therapy worth $36,963,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Principal Securities Inc. grew its position in shares of U.S. Physical Therapy by 24.7% during the fourth quarter. Principal Securities Inc. now owns 3,293 shares of the company's stock worth $292,000 after buying an additional 653 shares in the last quarter. Principal Financial Group Inc. grew its position in shares of U.S. Physical Therapy by 4.1% during the fourth quarter. Principal Financial Group Inc. now owns 83,091 shares of the company's stock worth $7,371,000 after buying an additional 3,274 shares in the last quarter. Truist Financial Corp grew its position in shares of U.S. Physical Therapy by 60.1% during the fourth quarter. Truist Financial Corp now owns 17,937 shares of the company's stock worth $1,591,000 after buying an additional 6,736 shares in the last quarter. Venturi Wealth Management LLC grew its position in shares of U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after buying an additional 704 shares in the last quarter. Finally, Illinois Municipal Retirement Fund grew its position in shares of U.S. Physical Therapy by 3.6% during the fourth quarter. Illinois Municipal Retirement Fund now owns 8,351 shares of the company's stock worth $741,000 after buying an additional 292 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. JPMorgan Chase & Co. lowered their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. JMP Securities reaffirmed a "market outperform" rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. Finally, Barrington Research lowered their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a report on Friday, February 28th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Trading Up 1.5%

NYSE:USPH traded up $1.15 during mid-day trading on Monday, reaching $75.43. The company's stock had a trading volume of 242,865 shares, compared to its average volume of 117,385. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $101.20. The company's fifty day simple moving average is $74.04 and its two-hundred day simple moving average is $80.32. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.17 and a quick ratio of 1.17. The stock has a market cap of $1.15 billion, a P/E ratio of 34.60, a P/E/G ratio of 3.60 and a beta of 1.45.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.02. The business had revenue of $183.79 million for the quarter, compared to analysts' expectations of $176.78 million. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The company's quarterly revenue was up 18.0% on a year-over-year basis. During the same period last year, the company earned $0.51 earnings per share. On average, equities analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 23rd were paid a $0.45 dividend. The ex-dividend date of this dividend was Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.39%. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 82.57%.

Insider Buying and Selling

In related news, Director Nancy Ham sold 400 shares of U.S. Physical Therapy stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the sale, the director now owns 2,594 shares in the company, valued at approximately $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.00% of the company's stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.